Please assess the completion status of the following clinical trial:

Trial Title: Effects of Continuous ESP Catheters on Recovery, Pain and Opioid Consumption After Multilevel Spine Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-80~* Presenting for elective multilevel (\>2 spinal levels) spinal fusion~* Lumbar, thoracic, and thoracolumbar procedures included~* Posterior surgical approach~* Willing and able to follow the study protocol~* Able to provide informed consent~Exclusion Criteria:~* Opioid tolerance (more than 60 morphine milliequivalents daily for more than 3 months)~* Daily gabapentin/pregabalin use for longer than 3 months~* Prior spine surgery at the index level~* Allergy or contraindication (including renal, liver disease) to included study medications~* Patient refusal

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- ESP Catheters with Ropivacaine 0.2% (Type: EXPERIMENTAL): None
- ESP Catheters with Saline Solution (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).